Reports for CHEPLAPHARM ARZNEIMITTEL GMBH

Company Name

CHEPLAPHARM ARZNEIMITTEL GMBH

Totals

Shortage reports

48

Actual shortage: 7 (15%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (2%)
Resolved: 40 (83%)

Discontinuation Reports

4

To be discontinued: 0 (0%)
Discontinued: 4 (100%)
Reversed: 0 (0%)

Late reports

4 (8%)

Overdue reports

4 (57%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ANANDRON 50MG TABLET Actual shortage 2023-09-14 2023-11-18 204346
ONE-ALPHA 2MCG SOLUTION LIQUID Actual shortage 2023-12-13 2024-01-22 213256
VALCYTE 450MG TABLET Resolved 2024-01-04 2024-02-01 214848
SUPREFACT 1MG SOLUTION Actual shortage 2024-02-27 2024-02-29 220741
VISUDYNE 15MG POWDER FOR SOLUTION Resolved 2024-01-04 2024-03-01 214845
FUNGIZONE 50MG POWDER FOR SOLUTION Actual shortage 2024-03-08 2024-03-12 221737
CYTOVENE 500MG POWDER FOR SOLUTION Resolved 2023-02-14 2024-03-14 184528
LOSEC MUPS 20MG TABLET (DELAYED-RELEASE) Actual shortage 2023-12-13 2024-04-26 213267

Showing 41 to 48 of 48

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LOSEC 20MG TABLET (DELAYED-RELEASE) Discontinued 2021-11-19 2021-11-19 149669
SUPREFACT 100MCG SOLUTION Discontinued 2021-12-13 2021-12-13 151039
XELODA 150MG TABLET Discontinued 2022-11-30 2022-12-01 176355
XELODA 500MG TABLET Discontinued 2022-11-30 2022-12-01 176359

Showing 1 to 4 of 4